{"database":"ENA","file_versions":[],"scores":null,"additional":{"omics_type":["Genomics"],"center_name":["Molecular Medicine, University of Padova"],"full_dataset_link":["https://www.ebi.ac.uk/ena/browser/view/PRJNA91225"],"scientific_name":["Homo sapiens"],"long_description":["To examine angiogenesis inhibitor-regulated pathways, the alteration in gene expression of human microvascular endothelial cells after a 4-hour treatment with seven chemically different inhibitors has been analyzed. Specifically, this series describes the expression profiles following treatment with either: 1. recombinant interferon-alpha (IFN-alpha) 2. pigment epithelium derived factor (PEDF) 3. all trans-retinoic acid (RA) 4. thrombospondin 1 (TSP-1) 5. TNP-470 (TNP-470) 6. endostatin (ENDO) 7. angiostatin (ANGIO). To ensure that cDNA products were proportional to the initial gene expression pattern, 33P-labelled probes from oligo d(T) primed reverse transcription of 5 microg RNA were generated for each. This, followed by second strand synthesis, was used to hybridize the nylon filters (GF211 ) comprising a total of 4132 genes and EST’s. Keywords = Homo sapiens Keywords = human micro vascular endothelial cell Keywords = angiogenesis Keywords = angiogenic inhibitors Keywords: other"],"tag":["xref:PubMed:12499246"],"repository":["ENA"],"additional_accession":[]},"is_claimable":false,"name":"Homo sapiens","description":"Trascriptional profiling of angiogenic inhibitors","dates":{"last_updated":"2025-09-24","first_public":"2014-02-11"},"accession":"PRJNA91225","cross_references":{"GEO":["GSE2177"],"taxon":["9606"],"PubMed":["12499246"]}}